Product Liability Archive » March, 2012

Product Liability - March, 2012

236 articles

• FDA Wants Tobacco Cos. To List Chemicals, Back Risk Claims
• NJ Court Rules State Claims Timely In Prison Defect Suit
• Bee Deaths Cause France To Rethink Syngenta Insecticide
• EPA Proposes Rule Restricting New PBDE Chemical Imports
• Investor Class Certified On Claims Pfizer Masked Drug Risks
• FDA Rebuffs BPA Ban For Now, Citing Lack Of Scientific Data
• BP Says US Docs Could Trim Deepwater Spill Estimate
• FDA Panel Says Obesity Drugs Need Tougher Clinical Trials
• Pfizer Urges JPML To Combine Zoloft Cases In NY
• Tobacco Cos. Say Australian Plain-Pack Law Violates Rights
• Ex-Milberg Attys Can't Duck Fee Battle With Former Firm
• Insurers Can't Shake General Refractories' Coverage Suit
• GOP Sen. Aims To Put The Brakes On Ethanol Fuel Suits
• Mercedes-Benz Escapes Class Cert. In Water Leak Suit
• New Safety Worries Spark FDA Scrutiny Of Metal Hip Implants
• Massey Can't Nix Stock-Drop Suit Over Mine Disaster
• Ex-Massey Boss Cops To Thwarting US Mine Safety Efforts
• NHTSA: Those Who Can't Set Standards, Issue Guidelines
• Mediation Fails In Specialty Products Asbestos Dispute
• FDA Could Make Generics Liable Amid Push To Undo Mensing
• WTC Plaintiffs' Attys Urge 2nd Circ. To Allow $42.5M Bonus
• Brazilian Workers Latest To Sue Chevron Over November Spill
• Lawmaker Urges FDA To Finalize Triclosan Regulations
• Fla. Appeals Court Affirms $3.4M Award To Smoker's Widow
• Cypress Pays $2.8M To Settle FCA Suit Over Unapproved Drugs
• FDA Revises Celexa Warnings Over Heart Disorder Risk
• Microsoft Evades Class Claims In Xbox 360 Defect Case
• Man Vs. Machine: Siri Doesn't Always Do As It's Told
• Must-Have Performance Metrics For Law Departments
• Omni's Fraud Claims Tossed Over Supplier's Defective Seals
• Bipartisan Senate Bill Aims To Hasten Key Drug Approvals
• Former C&H Sugar Employee's $5.5M Asbestos Win Stands
• FDA Sheds Light On Medical Device Risk Reviews
• Biotronik Wants $100M Suit Over J&J Stent Recall Reopened
• Congress Zeros In On New FDA Safety Rules For Cosmetics
• Judge Approves $158M Settlement Of J&J Risperdal Suit
• Kawasaki, Union Pacific Take Train Derailment Suit To 7th Circ.
• Merck Suit To Bar Ky. AG From Hiring Outside Attys Kept Alive
• Bill Would Allow Labeling Suits Against Generics Cos.
• The Question Of Personal Jurisdiction And Foreign Corps.
• Petrobras Demands $185M In Faulty Marine Chain Suit
• GAO Test Reveals Flood Of Counterfeit Parts From Chinese Cos.
• Expert Cleared To See Toyota's Secrets In Brake MDL
• Petition Over Prempro Injury Suits Turned Down By High Court
• AstraZeneca Can't Get FDA Tip-Off On Generic Approvals
• J&J Questions $158M Settlement Of Texas' Risperdal Suit
• FDA Considers Changes To Obesity Drug Clinical Trials
• BMW Recalls 1.3 Million Cars Worldwide Over Cable Problem
• Girardi & Keese Can't Shake Client Abandonment Claims
• Court Finds For Attransco In $10M Asbestos Appeal
• $50M Worth Of Tobacco Appeals Won't Get High Court Hearing
• Pa. High Court Rules J&J Not Liable In Surgery Death
• Dinsmore Grabs Ex-Chamber Counsel With Enviro, FDA Chops
• A 'Shocking' Claim Of Design Defect
• Ex-Weitz Atty Claims Firm Took Rival's Confidential Files
• Deepwater MDL Court Resolves $27M In Victims' Claims
• Canned Food Cos. Brace For FDA Action On BPA Packaging
• AstraZeneca Can't Prevent FDA Approval Of Generic Seroquel
• Roche Gets New Look On Timeliness Of Accutane Case
• GCs Predict Increase In Chemical, Biotech Mass Torts
• Judge Approves Monsanto Radiation Settlement Minus Class
• Engine Co. Wants Parts Maker To Fund Plane Crash Deal
• Judge Upholds Class Cert. In Acer Faulty Laptop Suit
• Merck Loses Challenge To Private Vioxx Prosecution
• Pfizer Can't Shake Fraud Suit Over Risky Arthritis Drugs
• Experts Say FDA Ignored Evidence In High-Dose Aricept Review
• Thousands Of Nigerians Sue Shell Over 2008 Oil Spills
• FDA Ordered To Target Antibiotics In Animal Feed
• BPA's Expiration Date May Be On Its Way
• Ill. High Court Keeps Asbestos Suit Against CSX Alive
• Ariz. Utility Dodges Spoiled-Food Class Claims
• Kroger Drops 'Pink Slime' Despite USDA Safety Assurances
• Philip Morris Loses Bid To Decertify Smokers Class
• DOJ Shouldn't Be Sanctioned In Bulletproof Vest Row: Judge
• Judge Trims Expert Testimony In Novartis Bone Drug Suit
• High Court Asked To Reinstate $26M Merck Vioxx Judgment
• Insurer Pays $11M To Settle Row Over Salmonella Recall
• Honda Owners File Class Action Over Oil-Thirsty Accords
• PG&E Says Post-Blast Pipeline Work Should Reduce Fines
• Smithfield Seeks $326M For Factory Fire Started By Marine
• Daubert At Class Certification: More Is All There Is
• Judge Won't Let Caterpillar Engine Defect Class Emerge
• Stryker's Wingspan Stent May Raise Stroke Risk, FDA Says
• Calif. Court Says FAA Guidelines Don't Trump State Law
• Stakeholders To Weigh In On Making More Drugs OTC
• NFL Suspends Saints Coach Amid Scrutiny Over Safety
• Chevron, Transocean Execs Charged Over Brazil Spill
• Shell, Conoco Pumped Village With Carcinogens, Suit Says
• Katrina Emissions Suit Against Oil Cos. Rejected Again
• Insurers Stuck In Asbestos Duty-To-Defend Suit
• Judge Tosses Calif. County's Vioxx Class Action
• Nationwide Units, Napa Strike $15M Burn Coverage Deal
• Made Abroad, Sued In The US: Managing Liability Risk
• Canada Places Cancer Warnings On Merck And GSK Drugs
• Hawaii AG Approves $15M Hiking Death Settlement
• Calif. Water District Gets Tentative OK In Coverage Suit
• Fatal Crash Spurs Change In F-22's Oxygen System
• FAA Should Probe Pilots' Commutes, DOT Inspector Warns
• Steptoe Snags Former Obama Adviser For Pipeline Team
• Judge Sinks Securities Class Action Against Transocean
• EPA Proposes Curbing 5 Chemicals In Consumer Products
• Swanson Brings In Toxic Tort Partner From HeplerBroom
• Pfizer To Pay Oregon $3.3M To End Zyvox Marketing Suit
• A Raw Deal For Tort Plaintiffs
• Travelers Settles Defective Slide Suit With Insurers
• OTC Drugmaker Says BioZone Breached Cold Meds Contract
• 6th Circ. OKs Graphic Ads On Cigarette Packs
• Anheuser-Busch Ducks Insurer's Asbestos Coverage Claim
• FDA Recalls Brilliant Blue G After Eye Infection Reports
• Report Ties Fracking To Harmful Air Pollution
• Dodgers, Beaten Fan Reach Deal On Bankruptcy Claim
• Presenting ... A Fresh Interpretation Of Old Policy
• US Fire Can't Escape Coverage Claims For Asbestos Suits
• Novartis Bone Drug Action Doomed By Statute Of Limitations
• 5th Circ. Nixes Remand Review In $20M Transocean Suit
• 1st Circ. Tosses Vicor's $13M Insurance Win In Ericsson Row
• US To Ease Beef Import Rules For Nations With Mad Cow Risks
• $170M Honda Gas Mileage Settlement Gets Final OK
• Judge Upholds Saudi Immunity In 9/11 Damages MDL
• Whistleblower Says BP Gulf Atlantis Plant Still Not Safe
• A Little Less Brotherly Love In The Mass Tort System
• EPA Finds No Fracking Contamination In Pa. Town's Water
• PG&E, Contractors Pay $30M To Douse Forest Fire Suits
• PG&E To Pay $3.6M To Settle Chromium Pollution Claims
• Ill. Appeals Court Axes Insurers' Chicago Sewer Fight
• 2nd Circ. Says No Chadbourne Conflict In Reinsurance Row
• Nationwide Class Loses Cert. Bid In HP Printer Defect Row
• Guidant Can't Kill $726M FCA Suit Over Implant Claims
• Shire Pulls US Drug Application, Blames FDA Delay
• The Ever-Broadening Reach Of Dukes
• Don't Try To Pull The Wool Over The FTC's Eyes
• Subaru Recalls Foresters Over Child Seatbelt Risk
• Professor Seeks FDA Probe Into Stem Cell Cos.' Practices
• EU, US Settle Trade Beef Over Meat Imports
• La. High Court Axes Punitive Damages In Citgo Oil Spill
• Suit Says Black & Decker Coffeemakers Are Defective
• The Awesome Power Collateral Estoppel Can Render
• Lawmakers Urge FDA To Label Genetically Engineered Foods
• Tobacco Cos. Ask DC Circ. To Keep Marketing Data From US
• Ascentive Pays $9.6M To End Sham Software Class Action
• FDA Warns Staples To Control Rodents At Calif. Warehouse
• Chevron Says Patton Boggs Is Dodging NY Judge In $21M Suit
• DC Circ. Foils Bid To Ban Mercury-Containing Vaccines
• Chevron, GCM Make Peace In Gas Station Cleanup Row
• Some Warner Chilcott Birth Control May Not Work, FDA Warns
• The Circuit Court Split On 'Fraud On The FDA' Continues
• 4th Circ. Nixes Wrongful Death Claim In Bayer Plant Blast
• AstraZeneca Sues FDA Over Generic Seroquel Labels
• Medtronic Investors Sue Over $3B Inflated Stock Buyback
• Sandoz, Others Escape Faulty Painkiller Patch Case
• Toyota Can't Force Arbitration In Faulty Acceleration MDL
• NHTSA Investigates Sticky Ford Taurus Throttles
• Judge Leaves Room For Leftovers In Samsung Fridge Suit
• Chartis Stuck With Suit Over Brazil Spill Coverage
• FDA To Review TV Drug Ads Before Broadcast
• Chrysler Can't Escape Defective Exhaust System Class Action
• GSK Skirts FCA Suit Over Physician Kickback Program
• 7th Circ. Says No Coverage For Polluting Town
• PG&E Hands San Bruno $70M To Resolve Explosion Claims
• Why Communications Is Key To Merger And Lateral Success
• 8th Circ. Nixes Contractor's Bid For $1M Defense Coverage
• Drugmaker Bryan Corp. Sues Supplier Over Ingredient Quality
• Consumers Say 500K VWs Burn Motor Oil Too Quickly
• EPA To Run New Tests In Wyo. Fracking Contamination Row
• Ex-Katten Atty Loses Spoliation Bid In Tishman Mold Row
• FDA Moves To Improve Tracking Of Drug Safety Issues
• FDA Approves Third Silicone Gel Breast Implant
• Travelers Calls Welding Products Co.'s Suit Premature
• Greenwich Sues To Avoid Coverage In Gas Explosion Suit
• Honda Paints Defect Suit As Bid To Whitewash Warranty
• EU Council Bans Sale Of Fruit Juices With Added Sugar
• Senate OKs Sending BP Oil Spill Penalties To Gulf
• Lockheed, Others Sued Over Faulty F-22 Components
• Tobacco Ads Spurred Minors To Smoke, Surgeon General Says
• Pepsi, Coke Alter Caramel Coloring To Escape Cancer Warning
• Judge OKs Kellogg's Expansion Of $70M Cereal Recall Suit
• Ex-Kirkland Toxic Tort Guru Jumps To Jones Day
• The Interplay Between FDA Approval And Discovery Rule
• Toyota Recalls 680K Autos Over Air Bags, Brake Lamps
• Ford Dodges $47M Suit Over Fatal Police Car Crash
• Takeda Hid Diabetes Drug's Heart Risks, Ex-Reviewer Says
• La. Appeals Court Revives Bayer Insecticide Action
• NY Senate Votes To Ban Cadmium In Children's Jewelry
• Engineering Co. Takes Minn. Bridge Collapse Suit To High Court
• A New Dimension To What Constitutes 'Design'?
• Chadbourne Product Liability Pro Leaps to LeClairRyan
• Okla. High Court Frees Tyson Of $10M Chicken Grower Verdict
• Boiron To Pay Up To $12M To End False Advertising Suits
• MSHA Review Cites Missed Violations Before Massey Blast
• FDA Squashes Most Of SC Farm's Tomato Recall Claims
• Lawmakers Demand Info On Agencies' Email Monitoring Rules
• Lorillard Owes $41M To Lung Cancer Widow, Jury Finds
• Garlock Must Give Financial Docs To Asbestos Claimants
• AeroShot Caffeine Inhaler Scrutinized By FDA
• FDA Finds Multiple Quality Violations At Synthes Plant
• PulteGroup Told To Cough Up $13.6M In Home Defects Fight
• Birth Defects — Prenatal Liability Or Workers Comp?
• Toyota's 1st Sudden Acceleration Trial Set For Nov.
• US To Appeal Ruling Nixing FDA's Cigarette Warning Labels
• Mensing Shields Generics Makers In Sprawling Darvocet MDL
• Trex Deck Warranty Claim Survives Despite 3rd-Party Sales
• Microsoft Dodges Class Cert. In Zune Defect Suits
• High Court To Probe Alien Tort Liability For Abuses Abroad
• Beaten Fan Rebuffs Dodgers' Bankruptcy Compromise
• Insurer Drops Appeal, Settles ABM Chinese Drywall Suit
• Tepco Faces $67B Suit Over Fukushima Meltdown
• FDA Rejects Merck's Combo Cholesterol Drug For Now
• A Cloak Of Invisibility Is A 'Don't' In The Courtroom
• Riceland, Liberty Mutual Settle GMO Rice Coverage Dispute
• Restore Act Would Send More BP Dollars To Gulf States
• Ongoing Deepwater MDL Claims Could Net Feds $21B
• Deepwater's Shake-Up Of Regulatory Landscape To Continue
• Judge Barbier Earns Praise For Shrewd Handling Of BP Case
• BP Settlement Dwarfs Top Product, Toxic Tort Deals
• 5th Circ. Backs Landmark Katrina Canal Breach Ruling
• Toyota Plaintiffs Lack Standing, Groups Tell 9th Circ.
• BP Wants 5th Circ. To Take Up Transocean Insurance Feud
• Ecuadorean Court Rejects Chevron Bid To Escape $18B Verdict
• First Financial Settles Faulty Pipeline Suit
• Merck Action Didn't Stop The Clock, Va. High Court Says
• Law360 Product Liability Editorial Advisory Board
• Va. High Court Sinks Some Awards In Maritime Death Cases
• Lorillard Hit With $20M Jury Verdict In Lung Cancer Suit
• BP Wants Prior Accident Testimony Barred From Trial
• Dodgers Offer Ch. 11 Trade-Off To Beaten Fan
• Unpeeling The Layers Of Recall, Contamination Policies
• BP Settles Private Oil Spill Claims For At Least $7.8B
• Smokers Push 2nd Circ. To Resurrect Philip Morris Suit
• Judge Frees Travelers From $500M Asbestos Settlements
• Jury Sides With Pfizer Unit In Prempro Breast Cancer Case
• FDA Warns Of 2 Hazardous Chemicals Used In Drugs
• FDA Delays Approval Of Pfizer-BMS Anti-Clotting Drug
• Dems Urge Push On Graphic Cigarette Labels In Wake Of Ban
• Reglan Failure-To-Warn Suit Brought To Supreme Court
• EU Says Baby Formula, Specialty Foods Need New Rules
• I'll Take One Order Of Liability, To Go